Remdesivir, Camostat Fail to Deliver in COVID-19 RCTs

 Two drugs that looked like promising treatments for COVID-19 in preliminary studies – remdesivir for hospitalized patients and camostat for patients who are not seriously ill – failed to show a benefit in those groups in randomized controlled trials, researchers reported in two separate papers. In five European countries, researchers […]